Live feed
Filing
SC 13D/A
SC 13D/A0001493152-18-007456·Lineage Cell Therapeutics, Inc.
Schedule 13D ownership disclosure
Asterias Biotherapeutics, Inc.
Security class unavailable · CUSIP: 04624N107
Event date: 2018-05-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 37.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-18-007456
- Form type
- SC 13D/A
- Filer
- Lineage Cell Therapeutics, Inc.
- CIK
- CIK 876343
- Filed
- May 18, 2018
- Reporting period
- May 15, 2018
- Description
- Schedule 13D beneficial ownership